Real-World Outcomes of Baricitinib Monotherapy Versus csDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy, Safety, and Drug Retention
Volume 40 - Issue 3 - September 2025, Page 279-287
Gülay Alp

Enter the code above.